-
Cellular kinetics associated with the development of acquired cellular resistance.
J Exp Med. 1969 Aug 1;130(2):299-314
PMID: 4978533
-
Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.
J Cell Biol. 1969 Nov;43(2):263-74
PMID: 4981070
-
Suppression of malignancy and differentiation in melanotic melanoma cells.
Proc Natl Acad Sci U S A. 1970 May;66(1):72-8
PMID: 4921328
-
In vitro nonimmunologic destruction of cells with abnormal growth characteristics by adjuvant activated macrophages.
Proc Soc Exp Biol Med. 1972 Mar;139(3):1049-52
PMID: 5023754
-
Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis.
J Natl Cancer Inst. 1972 May;48(5):1441-55
PMID: 4337912
-
Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine.
J Natl Cancer Inst. 1972 Jun;48(6):1697-707
PMID: 4341404
-
A human mononuclear leukocyte chemotactic factor: characterization, specificity and kinetics of production by homologous leukocytes.
J Immunol. 1973 Mar;110(3):801-10
PMID: 4688920
-
The interaction of particulate horseradish peroxidase (HRP)-anti HRP immune complexes with mouse peritoneal macrophages in vitro.
J Cell Biol. 1972 Dec;55(3):616-34
PMID: 4656704
-
Modification of malignancy by 5-bromodeoxyuridine. Studies of reversibility and immunological effects.
In Vitro. 1971 Sep-Oct;7(2):105-14
PMID: 5170776
-
Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG.
J Natl Cancer Inst. 1974 Jun;52(6):1887-95
PMID: 4857796
-
Immunoelectronmicroscopic analysis of surface antigens common to Mycobacterium bovis (BCG) and tumor cells.
J Natl Cancer Inst. 1974 Nov;53(5):1313-23
PMID: 4139279
-
Shared antigens between Mycobacterium bovis (BCG) and neoplastic cells.
J Natl Cancer Inst. 1974 Nov;53(5):1325-31
PMID: 4139280
-
Characterization of the macrophage receptro for complement and demonstration of its functional independence from the receptor for the Fc portion of immunoglobulin G.
J Exp Med. 1975 Jun 1;141(6):1269-77
PMID: 1092796
-
Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.
J Exp Med. 1975 Jun 1;141(6):1278-90
PMID: 1127381
-
Interaction of BCG-activated macrophages with neoplastic and nonneoplastic cell lines in vitro : quantitation of the cytotoxic reaction by release of tritiated thymidine from prelabeled target cells.
J Natl Cancer Inst. 1975 May;54(5):1177-84
PMID: 1092874
-
BCG inhibition of murine leudemia: local suppression and systemic tumor immunity require different doses.
Science. 1976 Jan 23;191(4224):299-301
PMID: 1108198
-
Macrophage activation and anti-tumor activity of biologic and synthetic agents.
Int J Cancer. 1976 Jan 15;17(1):82-9
PMID: 1248902
-
Isolation of a subpopulation of adherent peritoneal cells with anti-tumour activity.
Nature. 1976 Mar 11;260(5547):146-8
PMID: 768773
-
An inhibitor of macrophage chemotaxis produced by neoplasms.
Science. 1976 Apr 23;192(4237):370-2
PMID: 946556
-
A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Cancer Res. 1976 Dec;36(12):4459-66
PMID: 187324
-
2-Deoxyglucose selectively inhibits Fc and complement receptor-mediated phagocytosis in mouse peritoneal macrophages. I. Description of the inhibitory effect.
J Exp Med. 1976 Dec 1;144(6):1465-83
PMID: 1032901
-
Ionizing radiation and the immune response.
Adv Immunol. 1976;24:215-335
PMID: 14486
-
Decreased phagocytosis by peritoneal macrophages from BCG-treated mice: induction of the phagocytic defect in normal macrophages with BCG in vitro.
Cell Immunol. 1977 Mar 15;29(2):295-311
PMID: 324633
-
BCG-induced murine effector cells. II. Characterization of natural killer cells in peritoneal exudates.
J Immunol. 1977 Sep;119(3):1152-8
PMID: 330750
-
Biochemical and functional characteristics of the plasma membrane of macrophages from BCG-infected mice.
J Immunol. 1978 May;120(5):1532-6
PMID: 351053
-
The concept of the activated macrophage.
J Immunol. 1978 Sep;121(3):806-9
PMID: 80431
-
Activation of mononuclear phagocytes: fact, fancy, and future.
J Immunol. 1978 Sep;121(3):813-6
PMID: 357655
-
Extracellular cytolysis by activated macrophages and granulocytes. II. Hydrogen peroxide as a mediator of cytotoxicity.
J Exp Med. 1979 Jan 1;149(1):100-13
PMID: 216763
-
Systemic bacillus Calmette-Guérin (BCG) activates natural suppressor cells.
Proc Natl Acad Sci U S A. 1978 Oct;75(10):5142-4
PMID: 283421
-
Antitumor activity of peritoneal exudate cells induced by cell-wall skeleton of Mycobacterium bovis BCG.
Gan. 1978 Dec;69(6):831-4
PMID: 374173
-
Inhibition of in vitro cytotoxic responses by BCG-induced macrophage-like suppressor cells. II. Suppression occurs at the level of a "helper" T cell.
J Immunol. 1979 Jul;123(1):350-7
PMID: 156233
-
Human T lymphocyte subpopulations defined by Fc receptors and monoclonal antibodies. A comparison.
J Exp Med. 1980 Apr 1;151(4):969-74
PMID: 6445397
-
Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homografts.
J Immunol. 1961 Feb;86:228-39
PMID: 13785862
-
THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.
J Exp Med. 1965 Jan 1;121:153-70
PMID: 14253481
-
An analysis of the murine NK cell as to structure, function and biological relevance.
Immunol Rev. 1979;44:165-208
PMID: 367949
-
Natural killer cells: characteristics and regulation of activity.
Immunol Rev. 1979;44:43-70
PMID: 761939
-
Morphological and functional characterization of isolated effector cells responsible for human natural killer activity to fetal fibroblasts and to cultured cell line targets.
Immunol Rev. 1979;44:71-123
PMID: 367950